SEC Filing Details
Document Details
Form
Filing Date
2026-02-06 20:52:33
Document Date
2026-02-06 20:52:33
Form Description
AMENDMENT NO. 4 TO SCHEDULE 13E-3
Filing Group
Current Reports
Company
Lakeshore Biopharma Co., Ltd.
Issuer
Lakeshore Biopharma Co., Ltd.